- Advertisement -

Halved risk for severe retinal disease in extremely premature infants

Credit: Photo by Elin Lindstrom Risk for a severe form of retinopathy of prematurity, which can cause...

Strong link between gut bacteria and metabolites

There are strong links between bacteria living in the gut and the levels of small molecules in the blood known as metabolites. Such is...

EdiGene Biotechnology Moves into New R&D Center at Waltham, Mass. to Advance Proprietary LEAPER™ Technology into Transformative in vivo RNA Editing Therapies – Yahoo...

BEIJING & WALTHAM, Mass., November 07, 2022--(BUSINESS WIRE)--EdiGene, Inc., a global, clinical-stage company focused on translating its gene-editing technologies into transformative genetic medicines for...

Cell-Free Synthesis of Peptidomimetic Drugs by International Research Team

Peptide synthesis can create valuable therapeutics. One example is synthetic insulin. Nonetheless, peptide-based therapeutics face a range of challenges, including the inability to cross...

New super parallel computer system ‘KAGAYAKI’ based on Dell at JAIST...

Provides 2.24x higher performance than previous system Credit: JAIST and Dell Technologies Japan Advanced Institute of Science and...

UCR biochemist receives grant to develop novel lead compound to treat...

A biochemist at the University of California, Riverside, has received a grant from the Congressionally Directed Medical Research Programs, or CDMRP, of the U.S....

Johnson Matthey Partners with Basecamp Research on Biocatalysis Solutions

Johnson Matthey (JM), a specialty chemicals and sustainable technologies company, reports that it has partnered with Basecamp Research, which maps global biodiversity for computational biodesign applications,...

New drug combo fights breast cancer with brain metastases

A combination of two HER2-targeted drugs, tucatinib (Tukysa) and trastuzumab emtansine (Kadcyla, T-DM1), extended progression-free survival among patients with unresectable locally advanced or metastatic...

Johnson Matthey Partners with Basecamp Research on Biocatalysis Solutions

Johnson Matthey (JM), a specialty chemicals and sustainable technologies company, reports that it has partnered with Basecamp Research, which maps global biodiversity for computational biodesign applications,...

New drug combo fights breast cancer with brain metastases

A combination of two HER2-targeted drugs, tucatinib (Tukysa) and trastuzumab emtansine (Kadcyla, T-DM1), extended progression-free survival among patients with unresectable locally advanced or metastatic...

Fear of falls is associated with less physical activity for people in their nineties,...

Fear of falls is associated with less physical activity for people in their nineties, who averaged around 3,000 daily steps per activity tracker data Credit:...

more new items

Johnson Matthey Partners with Basecamp Research on Biocatalysis Solutions

Johnson Matthey (JM), a specialty chemicals and sustainable technologies company, reports that it has partnered with Basecamp Research, which maps global biodiversity for computational biodesign applications,...

New drug combo fights breast cancer with brain metastases

A combination of two HER2-targeted drugs, tucatinib (Tukysa) and trastuzumab emtansine (Kadcyla, T-DM1), extended progression-free survival among patients with unresectable locally advanced or metastatic...

Fear of falls is associated with less physical activity for people...

Fear of falls is associated with less physical activity for people in their nineties, who averaged around 3,000 daily steps per activity tracker data Credit:...